Although immune checkpoint blockade of CTLA4 axis is upper stream than the effects of PD-1 axis, NIR-PIT effects are still upstream of the targets of CTLA4 checkpoint inhibition in anti-cancer host immunity [1,3]. The gene discussed is PDCD1; the disease is cancer.